Nevro Corp. (NVRO)


+1.50 (+8.66%)
Symbol NVRO
Price $18.82
Beta 0.879
Volume Avg. 0.51M
Market Cap 681.388M
Shares () -
52 Week Range 13.98-46.71
1y Target Est -
DCF Unlevered NVRO DCF ->
DCF Levered NVRO LDCF ->
ROE -33.99% Strong Sell
ROA -18.24% Sell
Operating Margin -
Debt / Equity 67.88% Buy
P/E -6.56 Strong Sell
P/B 2.38 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest NVRO news

Mr. Kevin R. Thornal
Medical Devices
New York Stock Exchange

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.